Management of Hypercalcaemia
For adults with hypercalcemia of malignancy, treat with IV bisphosphonates or denosumab (preferably denosumab), and add calcitonin for 48-72 hours if calcium is >14 mg/dL (3.5 mmol/L). 1
Initial Assessment and Severity Stratification
Hypercalcemia severity determines treatment urgency:
- Mild: Serum calcium <12 mg/dL (3 mmol/L)
- Moderate: 12-14 mg/dL (3-3.5 mmol/L)
- Severe: >14 mg/dL (3.5 mmol/L) 1
The first critical step is measuring intact PTH to distinguish PTH-dependent from PTH-independent causes 2. An elevated or normal PTH indicates primary hyperparathyroidism (PHPT), while suppressed PTH (<20 pg/mL) points to malignancy, granulomatous disease, vitamin D toxicity, or other causes.
Treatment Algorithm by Etiology
Hypercalcemia of Malignancy (HCM)
This carries high morbidity and mortality, affecting 2-30% of cancer patients, most commonly with breast, lung, renal cancers, and multiple myeloma 1.
Primary treatment approach:
All HCM patients: Start IV bisphosphonate or denosumab immediately 1
- Denosumab is preferred over IV bisphosphonates due to superior efficacy 1
Severe HCM (calcium >14 mg/dL): Add calcitonin to the bisphosphonate/denosumab regimen 1
- Critical caveat: Limit calcitonin to 48-72 hours maximum due to tachyphylaxis 1
- Calcitonin provides rapid onset while awaiting bisphosphonate effect
Refractory/recurrent HCM on bisphosphonates: Switch to denosumab 1
Supportive care: IV hydration with normal saline is essential for all symptomatic or severe cases 2, 3
Primary Hyperparathyroidism (PHPT)
Mild, asymptomatic PHPT (calcium <1 mg/dL above upper limit, age >50, no skeletal/renal involvement): Observation with monitoring is appropriate 2
Symptomatic or meeting surgical criteria: Parathyroidectomy is the only curative treatment 3
Medical management when surgery contraindicated: Calcimimetics can be used 1
Parathyroid Carcinoma
This requires a staged approach based on severity:
Mild hypercalcemia with symptoms: Start with calcimimetics 1
Moderate to severe hypercalcemia: Use IV bisphosphonate or denosumab as initial therapy due to faster onset and better tolerability 1
Inadequate response to calcimimetic alone: Add IV bisphosphonate or denosumab 1
Inadequate response to bisphosphonate/denosumab alone: Add calcimimetic 1
Once calcium controlled: Consider surgery when feasible 1
Other Causes
Vitamin D intoxication or granulomatous disorders (sarcoidosis, some lymphomas): Glucocorticoids are the primary treatment as these conditions involve excessive intestinal calcium absorption 2
Medication-induced: Discontinue offending agents (thiazides, calcium/vitamin D supplements, vitamin A) 2
Kidney failure with hypercalcemia: Denosumab and dialysis may be indicated, as bisphosphonates are relatively contraindicated 2
Common Pitfalls to Avoid
Don't use calcitonin beyond 72 hours - it becomes ineffective due to tachyphylaxis 1
Don't use bisphosphonates as monotherapy in severe HCM - add calcitonin for the first 48-72 hours to bridge the gap until bisphosphonates take effect 1
Don't assume malignancy without checking PTH - approximately 90% of hypercalcemia is either PHPT or malignancy, and PTH distinguishes them 2
Don't operate on parathyroid carcinoma during severe hypercalcemia - control calcium first, then consider surgery 1
Don't use loop diuretics routinely - while historically recommended, adequate hydration is more important; forced diuresis is no longer standard 2
Monitoring and Prognosis
PHPT prognosis: Excellent with either surgical or medical management 2
HCM prognosis: Associated with poor survival, as it indicates advanced malignancy 2
The underlying cause must be definitively treated - chemotherapy for malignancy, parathyroidectomy for PHPT, or addressing the specific etiology - as acute calcium-lowering measures are temporizing 4.